Capricor Therapeutics
Capricor Therapeutics is a biotechnology company developing transformative cell and exosome-based therapies aimed at addressing rare diseases. Their lead product, Deramiocel (CAP-1002), is in late-stage development for Duchenne muscular dystrophy, while their proprietary StealthX™ exosome platform explores innovative solutions in targeted delivery and vaccinology.
No jobs found. Subscribe below to get notified when we find something for you.
Searching